• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Tokamak Energy     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : dbo:Organisation, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingcompanyschema:Organizationdul:Agentdul:SocialPersonagentwikidata:Q24229398OrganizationBusiness enterpriseorganisation New Facet based on Instances of this Class

Tokamak Energy is a fusion power research company based in the United Kingdom, established in 2009. The company employs over 200 people and holds over 50 families of patent applications. It has built several versions of tokamaks, in the form of spherical tokamaks, with the final aim of reaching commercial fusion power generation.One of the first was the copper-based ST-25; in 2015 this was upgraded with rare earth–barium–copper oxide (REBCO) high temperature superconductors (HTS) to the ST-25HTS. The most recent tokamak developed, the ST-40, reached 15 million degrees Celsius in 2018.Tokamak Energy is a spin-off of the Culham Centre for Fusion Energy based in Oxfordshire. As of April 2021, the company has raised over £117m from private investors including L&G Capital, Dr. Hans-Peter Wild,